Natasha Rees

Natasha Rees is an experienced healthcare professional currently serving as an ABHI Board Member since July 2023 and as the Business Unit Head for Baxter Healthcare Limited in the UK, Ireland, and Nordics for Infusion Therapies & Technologies since May 2023. With a career at Baxter International Inc. from April 2014 to May 2023, Natasha has held multiple leadership roles including Business Unit Head for Clinical Nutrition & Pharma and Med Del & Pharma, as well as Acting Business Unit Head. Prior to Baxter, Natasha worked at Verathon Inc. as a Regional Sales Manager and held various sales and marketing management positions at Systagenix, An Acelity Company. Natasha began their career as a Research Scientist at Johnson Matthey after earning a Master of Science in Chemistry with Industrial Experience from the University of Bristol.